Viewing data from:

CEVIMELINE HYDROCHLORIDE

ANDA

CEVIMELINE HYDROCHLORIDE | A216682 | RUBICON RESEARCH LTD

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: EVOXAC(TE code: AB)

API Supply Chain7 active DMFs

7 active API suppliers hold Drug Master Files for this ingredient.

ISHIHARA SANGYO KAISHA LTDCEVIMELINE HYDROCHLORIDE

DMF 130741998

EXCELLA GMBH AND CO KGCEVIMELINE HYDROCHLORIDE

DMF 222002008

APOTEX INCCEVIMELINE HYDROCHLORIDE HEMIHYDRATE

DMF 225092009

MATRIX PHARMACORP PRIVATE LTDCEVIMELINE HYDROCHLORIDE USP

DMF 249492011

SS PHARMA LLCCEVIMELINE HYDROCHLORIDE USP

DMF 385772023

KALINTIS HEALTHCARE PVT LTDCEVIMELINE HYDROCHLORIDE USP

DMF 388802023

APICORE LLCCEVIMELINE HYDROCHLORIDE USP

DMF 402232024

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 30MG

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Apr 6, 2023

No patent or exclusivity listings for this strength.